论文信息 - Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer. - 字舞流文

Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer.

U. Müller-Richter | A. Kübler | A. Seher | A. Fuchs | R. Brands | S. Hartmann | K. Maurus | L. Zwick